pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Oncology · news · pharmadog
← back to Oncology
News · Oncology
925
stories
May 8, 26
FDA Approves Zenocutuzumab for NRG1 Fusion+ Cholangiocarcinoma
onclive
May 8, 26
UT MD Anderson Shares Latest Research Breakthroughs
onclive
May 8, 26
Giants of Cancer Care Announces the 14th Annual Class of Inductees
onclive
May 8, 26
OncLive Weekly News Quiz (5/8/2026): Test Your Knowledge on Key Breast, Lung, and Pancreatic Cancer Updates
onclive
May 8, 26
Former FDA leaders, pharma speak out on mifepristone
stat
May 8, 26
The biotechs wear Prada
stat
May 8, 26
OncLive Polls Reveal Picks for Top Lung Cancer Abstracts at ASCO 2026
onclive
May 8, 26
Poll Results Highlight Breast Cancer Abstracts of Interest at ASCO 2026
onclive
May 8, 26
STAT+: The biotech news you need to read today
stat
May 8, 26
Lilly, Gilead lead pharma’s M&A boom
biopharma dive
May 8, 26
Dr Gruenbaum on Where Alternative Options to BTK Inhibitors Stand in MCL
onclive
May 8, 26
The PYNNACLE Phase 2 trial assessing rezatapopt, a selective p53 reactivator, in patients with advanced or metastatic solid tumors harboring a TP53 Y220C mutation: Interim analysis of patients with ovarian cancer
onclive
May 8, 26
Characterization and Management of Sevabertinib induced Diarrhea in the SOHO 1 study
onclive
May 8, 26
Cumulative ADC Toxicities and Closing Reflections: Managing Edema, Fatigue, and Optimizing Long-Term Tolerability
onclive
May 8, 26
Why we left the FDA: Six former officials share their stories
stat
May 7, 26
Dr Sznol on Optimal Treatment Sequencing in Melanoma
onclive
May 7, 26
Mentorship Is Key to Advance the Next Generation of Oncology Researchers
onclive
May 7, 26
Dr Mauro on the Significance of Alternative TKI Formulations in CML
onclive
May 7, 26
Women With Bladder Cancer Face Diagnostic Delays as Symptoms Mimic UTIs, Experts Warn
onclive
May 7, 26
Seaport’s IPO adventure, obesity pill battles, and Makary’s troubles
stat
May 7, 26
Science is becoming less disruptive. Is an aging workforce to blame?
stat
May 7, 26
Dr Olawaiye on the FDA Approval of Relacorilant Plus Nab-Paclitaxel in PROC
onclive
May 7, 26
Official leading CDC’s cruise ship program retires
stat
May 7, 26
Daraxonrasib Monotherapy Elicits Meaningful Responses in Previously Treated, RAS-Mutated Pancreatic Cancer
onclive
May 7, 26
Sylvester Comprehensive Cancer Center Identifies a Screening Gap to Prevent a Type of Leukemia in the U.S.
onclive
May 7, 26
EnGene's shares crash on updated pivotal bladder cancer data
endpoints
May 7, 26
ASCO 2026 TNBC Deep Dive: Breast Cancer Experts Preview Practice-Informing Studies
onclive
May 7, 26
Roche to acquire digital pathology firm PathAI in deal potentially worth over $1B
biopharma dive
May 7, 26
STAT+: Pharmalittle: We’re reading about Sanofi and an FDA voucher, FDA rethinking a rejection, and more
stat
May 7, 26
STAT+: FDA revisits a rare cancer treatment it rejected a few months ago
stat
← prev
page 27 of 31
next →
